The cancer program at Cooperman Barnabas Medical Center in Livingston was again granted a three-year accreditation from the Commission on Cancer, it was announced this week.
To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive patient-centered care.
CBMC was recognized for taking a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists and other cancer specialists. This multidisciplinary partnership results in improved patient care.
Cooperman Barnabas Medical Center, an RWJBarnabas Health facility, works in partnership with Rutgers Cancer Institute of New Jersey.
Together with Rutgers Cancer Institute and RWJBarnabas Health, CBMC is a leader in cancer care and innovation and, in alignment with the theme of “Reimagining Cancer Care,” will open a 137,000-square-foot outpatient cancer center on its Livingston campus in 2025.
The freestanding facility will serve as the northern hub for the integrated oncology services offered by RWJBH and Rutgers Cancer Institute, bringing medical, surgical and radiation oncology services along with holistic support services under one roof.
“Earning this prestigious accreditation again is a testament to the unparalleled expertise and quality of care our cancer team at Cooperman Barnabas Medical Center offers our patients and community across the continuum of cancer care services,” CBMC CEO Richard Davis said.
“Together, we deliver evidence-based medicine and clinical research through advanced cancer therapies, the latest technologies and access to clinical trials, many of which are not available elsewhere. The addition of our new freestanding cancer center will build on the medical center’s longstanding legacy of clinical expertise and compassionate, patient-centered diagnosis and treatment.”
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive, quality care. Its membership includes fellows of the American College of Surgeons.
